Drug
Sodium Hyaluronate Injection
Sodium Hyaluronate Injection is a pharmaceutical drug with 4 clinical trials. Currently 2 active trials ongoing.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
2(50%)
Phase Distribution
Ph not_applicable
1
25%
Ph phase_4
2
50%
Ph phase_3
1
25%
Phase Distribution
0
Early Stage
0
Mid Stage
3
Late Stage
Phase Distribution4 total trials
Phase 3Large-scale testing
1(25.0%)
Phase 4Post-market surveillance
2(50.0%)
N/ANon-phased studies
1(25.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
4
all time
Status Distribution
Active(2)
Other(2)
Detailed Status
unknown2
Recruiting2
Development Timeline
Analytics
Development Status
Total Trials
4
Active
2
Success Rate
N/A
Most Advanced
Phase 4
Trials by Phase
Phase 31 (25.0%)
Phase 42 (50.0%)
N/A1 (25.0%)
Trials by Status
unknown250%
recruiting250%
Recent Activity
2 active trials
Showing 4 of 4
recruitingphase_3
Allogenic Adipose-Derived Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis
NCT06570291
recruitingnot_applicable
Effect of Platelet-rich Plasma (PRP) Injection on Knee Osteoarthritis
NCT06082531
unknownphase_4
Clinical Study of Artz in the Treatment of Knee Osteoarthritis
NCT02826031
unknownphase_4
Medical Chitosan or Sodium Hyaluronate for Knee Osteoarthritis (CHOOSE)
NCT02323451
Clinical Trials (4)
Showing 4 of 4 trials
NCT06570291Phase 3
Allogenic Adipose-Derived Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis
NCT06082531Not Applicable
Effect of Platelet-rich Plasma (PRP) Injection on Knee Osteoarthritis
NCT02826031Phase 4
Clinical Study of Artz in the Treatment of Knee Osteoarthritis
NCT02323451Phase 4
Medical Chitosan or Sodium Hyaluronate for Knee Osteoarthritis (CHOOSE)
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4